// App-Quantinova.ai

227 : The BARCODE1 pilot study targeting men with increased genetic risk of developing prostate cancer: Examining the feasibility of a community-based screening program using polygenic risk score to target screening.

Researchers

Presenter

  • Jana Kathlyn McHugh

Principal Investigators

  • Sarah Benafif

  • Holly ni Raghallaigh

  • Elizabeth Bancroft

  • Zsofia Kote-Jarai

  • Ros A. Eeles

Medical Centers

  • Institute for Cancer Research, London, United Kingdom

  • The Institute of Cancer Research, Sutton, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved